Lifestyle intervention and adipokine levels in subjects at high risk for type 2 diabetes: The Study on Lifestyle intervention and Impaired glucose tolerance Maastricht (SLIM)

Diabetes Care

Volumn 30, Issue 12, 2007, Pages 3125-3127

  Corpeleijn, Eva ^a,d   Feskens, Edith J M ^b,c   Jansen, Eugéne H J M ^c   Mensink, Marco ^a   Saris, Wim H M ^a   Blaak, Ellen E ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; BIOLOGICAL MARKER;

ARTICLE; CONTROLLED STUDY; DIET; EXERCISE; GLUCOSE METABOLISM; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIFESTYLE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT;

ADIPOKINES; ADIPONECTIN; BIOLOGICAL MARKERS; BODY SIZE; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; EXERCISE; FEMALE; GLUCOSE INTOLERANCE; HUMANS; LEPTIN; LIFE STYLE; MALE; REFERENCE VALUES; RESISTIN;

EID: 37149012401     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0457     Document Type: Article

References (23)

1. Arner P: Insulin resistance in type 2 diabetes: role of the adipokines. Curr Mol Med 5:333-339, 2005
2. Duncan BB, Schmidt MI: The epidemiology of low-grade chronic systemic inflammation and type 2 diabetes. Diabetes Technol Ther 8:7-17, 2006
3. Monzillo LU, Hamdy O, Horton ES, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Mantzoros CS: Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 11:1048-1054, 2003
4. Bluher M, Brennan AM, Kelesidis T, Kratzsch J, Fasshauer M, Kralisch S, Williams CJ, Mantzoros CS: Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care 30:280-285, 2007
5. Mensink M, Blaak EE, Corpeleijn E, Saris WH, de Bruin TW, Feskens EJ: Lifestyle intervention according to general recommendations improves glucose tolerance. Obes Res 11:1588-1596, 2003
6. Mensink M, Corpeleijn E, Feskens EJ, Kruijshoop M, Saris WH, de Bruin TW, Blaak EE: Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results. Diabetes Res Clin Pract 61:49-58, 2003
7. Durnin JV, Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77-97, 1974
8. Corpeleijn E, Feskens EJ, Jansen EH, Mensink M, Saris WH, de Bruin TW, Blaak EE: Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: the SLIM study. Diabetologia 49:2392-2401, 2006
9. Pasman WJ, Westerterp-Plantenga MS, Saris WH: The effect of exercise training on leptin levels in obese males. Am J Physiol 274:E280-E286, 1998
10. Montez JM, Soukas A, Asilmaz E, Fayzikhodjaeva G, Fantuzzi G, Friedman JM: Acute leptin deficiency, leptin resistance, and the physiologic response to leptin withdrawal. Proc Natl Acad Sci U S A 102:2537-2542, 2005
11. Steinberg GR, Parolin ML, Heigenhauser GJ, Dyck DJ: Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am J Physiol Endocrinol Metab 283:E187-E192, 2002
12. Fruhbeck G: Intracellular signalling pathways activated by leptin. Biochem J 393:7-20, 2006
13. Lazzer S, Vermorel M, Montaurier C, Meyer M, Boirie Y: Changes in adipocyte hormones and lipid oxidation associated with weight loss and regain in severely obese adolescents. Int J Obes (Lond) 29:1184-1191, 2005
14. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86:3815-3819, 2001
15. Hulver MW, Zheng D, Tanner CJ, Houmard JA, Kraus WE, Slentz CA, Sinha MK, Pories WJ, MacDonald KG, Dohm GL: Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 283:E861-E865, 2002
16. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289:1799-1804, 2003
17. Aas AM, Seljeflot I, Torjesen PA, Diep LM, Thorsby PM, Birkeland KI: Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes. Diabetologia 49:872-880, 2006
18. Bobbert T, Rochlitz H, Wegewitz U, Akpulat S, Mai K, Weickert MO, Mohlig M, Pfeiffer AF, Spranger J: Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 54:2712-2719, 2005
19. Abbasi F, Chang SA, Chu JW, Ciaraldi TP, Lamendola C, McLaughlin T, Reaven GM, Reaven PD: Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am J Physiol Regul Integr Comp Physiol 290:R139-R144, 2006
20. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T: Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. J Biol Chem 278:40352-40363, 2003
21. Page ST, Herbst KL, Amory JK, Coviello AD, Anawalt BD, Matsumoto AM, Bremner WJ: Testosterone administration suppresses adiponectin levels in men. J Androl 26:85-92, 2005
22. Chevillotte E, Giralt M, Miroux B, Ricquier D, Villarroya F: Uncoupling protein-2 controls adiponectin gene expression in adipose tissue through the modulation of reactive oxygen species production. Diabetes 56:1042-1050, 2007
23. Rubin D, Helwig U, Nothnagel M, Lemke N, Schreiber S, Folsch UR, Doring F, Schrezenmeir J: Postprandial plasma adiponectin decreases after glucose and high fat meal and is independently associated with postprandial triacylglycerols but not with - 11388 promoter polymorphism. Br J Nutr. 30 July 2007 [Epub ahead of print]